BioNTech SE (BNTX) Return on Sales (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, up 6.0% from the prior year.
• Return on Sales slipped to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2021 and bottomed at 0.25% in Q2 2024.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2024 — Return on Sales retreated 21 bps — and 2025, when it increased 23 bps.
• Year by year, Return on Sales stood at 0.01% in 2021, then sank by 53 bps to 0.01% in 2022, then grew by 10 bps to 0.01% in 2023, then plunged by 51 bps to 0.0% in 2024, then plunged by 157 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison